A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal
spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of
seasonal allergic rhinitis caused by pollen. Ciclesonide will be administered once during the
exposure to ragweed pollen in a controlled environment. The study duration consists of a
baseline period (up to 5 days) and a treatment period (1 day). The study will provide further
data on safety and tolerability of ciclesonide.